About Marc Centrella
Marc Centrella is a director at Evia Bio.
Experience
This experience comes from Marc Centrella's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marc Centrella in the role, so the role may have started earlier or lasted longer.
TB
Translucence Biosystems Current
Incoming Board Member
2026 – Present
MY
MycoFold Current
Co-Founder, CEO
2025 – Present
Evia Bio, Inc. Current
Director
2023 – Present · Minneapolis, MN
Cell preservation products and services for cell therapy companies.
PB
Parhelia Biosciences Current
Board Member
2023 – Present
CI
Cellular Engineering Technologies Inc.
Chief Executive Officer
2023 – 2025
AV
Avantor/VWR
Vice President, Corporate Strategy / M&A
2019 – 2022
RC
Repligen Corporation
Vice President Business Development and Strategy
2018 – 2019
BD
BD
Senior Director, Corporate Development
2015 – 2018
CS
Catalent Pharma Solutions
Director, Corporate Development
2013 – 2015
DB
Deutsche Bank
Vice President Investment Banking
2011 – 2013
JM
J.P. Morgan
Investment Banking Associate
2010 – 2011
BS
Banc of America Securities
Investment Banking Analyst
2006 – 2009
BA
Bayer
Financial Analyst - Controllers & Financial Planning & Analysis
2002 – 2005
Key Colleagues at Startups
The people Marc Centrella works with at each company, as listed on that company's latest Form D.
Evia Bio, Inc. · Form D, Sep 28, 2026
Allison Hubel
Founder and Scientific Advisor, director
SF
Scott Fisher
Director
Jeffrey Allen
Chairman & CEO
TW
Troy Wichterman
Director